(RTTNews) - Wave Life Sciences Ltd. (WVE), an RNA medicines-focused clinical-stage biotechnology firm, is set to announce interim data from its ongoing Phase 1 clinical trial evaluating WVE-007, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback